Medication adherence feedback intervention predicts improved human immunodeficiency virus clinical markers

International Journal of Nursing Practice

Volumn 19, Issue 6, 2013, Pages 577-583

  Reich, Warren A ^a  

^a Family Center   (United States)

Author keywords

CD4; Electronic monitoring; Medication adherence; Viral load

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMAN; MALE; MIDDLE AGED; PATIENT COMPLIANCE; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; VIRAL LOAD;

EID: 84890169501     PISSN: 13227114     EISSN: 1440172X     Source Type: Journal    
DOI: 10.1111/ijn.12100     Document Type: Article

References (39)

1. Chesney M. Adherence to HAART regimens. AIDS Patient Care and STDs 2003; 17: 169-177.
2. Robbins G, Daniels B, Zheng H, Chueh H, Meigs J, Freedberg K. Predictors of antiretroviral treatment failure in an urban HIV clinic. Journal of Acquired Immune Deficiency Syndromes 2007; 44: 30-37.
3. Wood E, Hogg R, Yip B, Harrigan P, O'Shaughnessy M, Montaner J. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350x10(9) cells/L. Annals of Internal Medicine 2003; 139: 810-816.
4. Shuter J. Forgiveness of non-adherence to HIV-1 antiretroviral therapy. The Journal of Antimicrobial Chemotherapy 2008; 61: 769-773.
5. Levine A, Hinkin C, Marion S etal. Adherence to antiretroviral medications in HIV: Differences in data collected via self-report and electronic monitoring. Health Psychology 2006; 25: 329-335.
6. Chesney M, Ickovics J, Chambers D etal. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care 2000; 12: 255-266.
7. Johnson C, Heckman T, Hansen N, Kochman A, Sikkema K. Adherence to antiretroviral medication in older adults living with HIV/AIDS: A comparison of alternative models. AIDS Care 2009; 21: 541-551.
8. Hammer S, Saag M, Schechter M etal. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA: the Journal of the American Medical Association 2006; 296: 827-843.
9. Freedberg K, Hirschhorn L, Schackman B etal. Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 2006; 43 (Suppl. 1): S113-S118.
10. Goldie S, Paltiel A, Weinstein M etal. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. The American Journal of Medicine 2003; 115: 632-641.
11. Schackman B, Finkelstein R, Neukermans C, Lewis L, Eldred L. The cost of HIV medication adherence support interventions: Results of a cross-site evaluation. AIDS Care 2005; 17: 927-937.
12. Chaiken S. Heuristic versus systematic information processing and the use of source versus message cues in persuasion. Journal of Personality and Social Psychology 1980; 39: 752-766.
13. Cacioppo JT, Petty RE, Kao CF, Rodriguez R. Central and peripheral routes to persuasion: An individual difference perspective. Journal of Personality and Social Psychology 1986; 51: 1032-1043.
14. Symonds CS, Johnson BT. The self-reference effect in memory: A meta-analysis. Psychological Bulletin 1997; 121: 371-394.
15. Noar SM, Benac CN, Harris MS. Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychological Bulletin 2007; 133: 673-693.
16. Epstein L, Cluss P. A behavioral medicine perspective on adherence to long-term medical regimens. Journal of Consulting and Clinical Psychology 1982; 50: 950-971.
17. Kozuki Y, Schepp K. Visual-feedback therapy for antipsychotic medication adherence. International Clinical Psychopharmacology 2006; 21: 57-61.
18. Otsuki M, Eakin M, Rand C etal. Adherence feedback to improve asthma outcomes among inner-city children: A randomized trial. Pediatrics 2009; 124: 1513-1521.
19. Ryan R, Deci E. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. The American Psychologist 2000; 55: 68-78.
20. Williams G, Rodin G, Ryan R, Grolnick W, Deci E. Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychology 1998; 17: 269-276.
21. Kennedy S, Goggin K, Nollen N. Adherence to HIV medications: Utility of the theory of self-determination. Cognitive Therapy and Research 2004; 28: 611-628.
22. Davies G, Koenig L, Stratford D etal. Overview and implementation of an intervention to prevent adherence failure among HIV-infected adults initiating antiretroviral therapy: Lessons learned from Project HEART. AIDS Care 2006; 18: 895-903.
23. Koenig L, Pals S, Bush T, Pratt Palmore M, Stratford D, Ellerbrock T. Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychology 2008; 27: 159-169.
24. Kimmerling M, Wagner G, Ghosh-Dastidar B. Factors associated with accurate self-reported adherence to HIV antiretrovirals. International Journal of STD and AIDS 2003; 14: 281-284.
25. Wagner G. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care and STDs 2002; 16: 599-608.
26. Smith S, Rublein J, Marcus C, Brock T, Chesney M. A medication self-management program to improve adherence to HIV therapy regimens. Patient Education and Counseling 2003; 50: 187-199.
27. Rosen M, Dieckhaus K, McMahon T etal. Improved adherence with contingency management. AIDS Patient Care and STDs 2007; 21: 30-40.
28. Sabin L, DeSilva M, Hamer D etal. Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China. AIDS and Behavior 2010; 14: 580-589.
29. Rosen M, Rigsby M, Salahi J, Ryan C, Cramer J. Electronic monitoring and counseling to improve medication adherence. Behaviour Research and Therapy 2004; 42: 409-422.
30. Arnsten J, Demas P, Farzadegan H etal. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases 2001; 33: 1417-1423.
31. Martin S, Elliott-DeSorbo D, Calabrese S etal. A comparison of adherence assessment methods utilized in the United States: Perspectives of researchers, HIV-infected children, and their caregivers. AIDS Patient Care and STDs 2009; 23: 593-601.
32. Bachhuber M, Bilker W, Wang H, Chapman J, Gross R. Is antiretroviral therapy adherence substantially worse on weekends than weekdays? Journal of Acquired Immune Deficiency Syndromes 2010; 54: 109-110.
33. Ryan G, Wagner G. Pill taking 'routinization': A critical factor to understanding episodic medication adherence. AIDS Care 2003; 15: 795-806.
34. Ironson G, Hayward H. Do positive psychosocial factors predict disease progression in HIV-1? A review of the evidence. Psychosomatic Medicine 2008; 70: 546-554.
35. O'Cleirigh C, Ironson G, Weiss A, Costa P. Conscientiousness predicts disease progression (CD4 number and viral load) in people living with HIV. Health Psychology 2007; 26: 473-480.
36. Boarts J, Sledjeski E, Bogart L, Delahanty D. The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS and Behavior 2006; 10: 253-261.
37. Simoni J, Frick P, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychology 2006; 25: 74-81.
38. Vervoort S, Grypdonck M, de Grauwe A, Hoepelman A, Borleffs J. Adherence to HAART: Processes explaining adherence behavior in acceptors and non-acceptors. AIDS Care 2009; 21: 431-438.
39. Westling E, Garcia K, Mann T. Discovery of meaning and adherence to medications in HIV-infected women. Journal of Health Psychology 2007; 12: 627-635.